Amneal Pharmaceuticals Announces Acquisition of Kashiv BioSciences for $750 Million Plus Contingent Payments

Skadden has advised Goldman Sachs as financial advisor to Amneal Pharmaceuticals. Holland & Knight and Dhinal Shah Associates have advised Kashiv BioSciences. Amneal Pharmaceuticals has announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here